NCT04905979Phase 2Completed

Trial of AD113 and Atomoxetine in OSA Patients With Hypertension

Study sponsor: Apnimed

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2023-01-31Actual
Enrollment · participants21Actual
Source updated2023-08-21Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.

Explore older trial changes

Upgrade to Pro to see the full available history for this trial.

Upgrade to Pro Illustrative preview